PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.
Pinato DJ, Cortellini A, Sukumaran A, Cole T, Pai M, Habib N, Spalding D, Sodergren MH, Martinez M, Dhillon T, Tait P, Thomas R, Ward C, Kocher H, Yip V, Slater S, Sharma R.
Pinato DJ, et al.
BMC Cancer. 2021 Mar 23;21(1):301. doi: 10.1186/s12885-021-08033-x.
BMC Cancer. 2021.
PMID: 33757459
Free PMC article.
Clinical Trial.